Brief: CytoTools: Dermapro Gets Marketing Approval In India
Oct 31 (Reuters) - CYTOTOOLS AG T5OG.DE :
* WOUND HEALING PRODUCT DERMAPRO OF SUBSIDIARY DERMATOOLS
BIOTECH
GMBH HAS RECEIVED MARKETING APPROVAL FOR THE INDICATION DIABETIC
FOOT IN INDIA.
* WITH THIS MARKET APPROVAL, PREPARATIONS ARE NOW BEGINNING
TO
ENTER THE INDIAN MARKET
Source text for Eikon: ID:nEQ7gdQgda
Further company coverage: T5OG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on bioXXmed AG
See all newsBrief: CytoTools Announces Completion Of Capital Increase
Brief: CytoTools - Disputes Between CytoTools, DermaTools, Shareholders Ended
Brief: CytoTools Announces Retirement Of Two Members Of Management Board
Brief: CytoTools Sees Complete Change Of Management Board And Supervisory Board Possible
Lordstown Motors says hedge fund may buy up to $400 mln of its stock (updated)